...
...

sanofi news

Sanofi to buy Blueprint Medicines for $9.1 Billion equity value

Sanofi will pay $129 per share in cash, the companies said in a statement Monday.
Updated on Jun 02, 2025 04:55 pm IST

Drug giants eye China for deals despite growing Sino-US tensions

Drug giants eye China for deals despite growing Sino-US tensions
Published on Jul 23, 2024 07:43 am IST

Edinburgh university researchers find 5 key genes linked to severe Covid-19

This electron microscope image made available and color-enhanced by the National Institute of Allergy and Infectious Diseases Integrated Research Facility in Fort Detrick, Md., in 2020, shows Novel Coronavirus SARS-CoV-2 virus particles, orange, isolated from a patient.
Published on Dec 11, 2020 11:36 pm IST

Sanofi, GSK Covid-19 vaccine to be ready only at the end of 2021

France’s Sanofi and Britain’s GSK said Friday their Covid-19 vaccines will not be ready until the end of 2021, after interim results showed a low immune response in older adults
Updated on Dec 11, 2020 01:32 pm IST

Sanofi reports positive animal test results for potential Covid-19 vaccine

There is no internationally-approved vaccine to protect against Covid-19, which has killed more than 1 million people around the world and triggered economic chaos.
Published on Oct 15, 2020 05:51 pm IST

Novavax to explore combined influenza/Covid-19 vaccine for use post pandemic

Novavax is among global drugmakers racing to develop a vaccine for Covid-19 and last month started a late-stage trial of its experimental vaccine, NVX-CoV2373, in the United Kingdom.
Published on Oct 13, 2020 07:04 pm IST

GlaxoSmithKline CEO optimistic Covid-19 vaccine widely available in 2021

The group’s most advanced project is with French partner Sanofi and the two have said they hope to get approval for their candidate next year.
Published on Sept 30, 2020 08:55 am IST

Covid-19: What you need to know today

A reading of the protocols shows (warning: they make for heavy reading) that the J&J trial is the only one measuring the efficacy of the vaccine in preventing severe and critical cases of Covid-19.
Updated on Sept 25, 2020 02:40 am IST

Sanofi and GSK launch trial for Covid-19 protein-based vaccine

This vaccine candidate uses the same recombinant protein-based technology as one of Sanofi’s seasonal influenza vaccines with GSK’s established pandemic adjuvant technology.
Published on Sept 03, 2020 10:55 am IST

Britain signs supply deal for 60 million doses of Sanofi/GSK Covid-19 vaccine

Sanofi and GSK, which had first teamed up in April, confirmed in a statement that regulatory approval for their vaccine could be won by the first half of 2021 if clinical data was positive.
Updated on Jul 29, 2020 11:39 am IST

Regeneron, Sanofi arthritis drug fails Covid-19 study

A separate Sanofi-led trial of Kevzara outside of the United States in hospitalized patients with severe and critical Covid-19 using a different dosing regimen is ongoing, the companies said.
Published on Jul 03, 2020 07:51 am IST

Is it a Respiratory Allergy due to air pollution or a seasonal common cold

Is it a Respiratory Allergy due to air pollution or a seasonal common cold? Watch this video to find out more!
Updated on Jan 30, 2021 03:39 pm IST

AstraZeneca to make billion Covid vaccine doses if tests succeed

Only a handful of the vaccines in development have advanced to human trials, an indicator of safety and efficacy, and the stage at which most fail.
Published on May 21, 2020 02:06 pm IST

Sanofi to enroll thousands for its coronavirus vaccine trials

Sanofi will bring in a protein antigen - a molecule designed to trigger an immune response in the body - based on a platform it uses for its influenza vaccine Flublok.
Published on May 06, 2020 03:24 pm IST

How you can take charge of your allergies? Watch this video and find out!

Dr. Nameet Jerath was one of the panelists at Let’s Talk Allergies - Part 1
Updated on Oct 10, 2023 07:24 pm IST